This grant funds innovative medical education programs to improve healthcare professionals’ knowledge and management of pulmonary fibrosis, focusing on diagnosis, treatment advances, and clinical research.
Funder: Bristol Myers Squibb Foundation
Due Dates: May 18, 2026 (Pulmonary Fibrosis IME RFE-26-IM-101)
Funding Amounts: Up to $125,000–$200,000 per award; single or multi-supported initiatives considered.
Summary: Supports innovative, independent medical education programs addressing knowledge gaps in pulmonary fibrosis for healthcare professionals.
Key Information: Accredited providers only; geographic restrictions apply (US, Spain, France, Germany, Italy; UK HCPs excluded).
The Bristol Myers Squibb Foundation is inviting proposals for independent medical education (IME) initiatives focused on pulmonary fibrosis (including idiopathic pulmonary fibrosis [IPF] and progressive pulmonary fibrosis [PPF]). This opportunity aims to support comprehensive, innovative, and engaging education that addresses unmet needs in the diagnosis, pathophysiology, and management of pulmonary fibrosis, as well as the latest advances in treatment and clinical research. The IME department publishes Requests for Education (RFEs) to address specific knowledge gaps; this RFE (RFE-26-IM-101) seeks to enhance clinician knowledge, competence, and patient outcomes in pulmonary fibrosis.